Form 4 for ALT Altimmune, Inc.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-07-01 · accession 0001104659-22-077433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-05 | 2022-07-01+ | ALT | Roberts M Scot | CSO | M - OptEx | $2.90 | +27.8K | 18.5K | New | +$80.5K |
| DM | 2022-07-05 | 2022-07-01+ | ALT | Roberts M Scot | CSO | S - Sale+OE | $12.00 | -37.2K | 17.7K | -68% | -$446.0K |
| DM | 2022-07-05 | 2022-07-01+ | ALT | Roberts M Scot | CSO | M - OptEx | $0.00 | -27.8K | 8,750 | -76% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2022-07-01 | M | A | 4,019 | $2.60 | 21,719 | D | — | — | |
| 2 | Common | Common Stock, par value $0.0001 | 2022-07-05 | S | D | 10,182 | $12.00 | 8,305 | D | — | — | |
| 3 | Common | Common Stock, par value $0.0001 | 2022-07-01 | M | A | 22,963 | $2.95 | 44,682 | D | — | — | |
| 4 | Common | Common Stock, par value $0.0001 | 2022-07-05 | M | A | 787 | $2.95 | 18,487 | D | — | — | |
| 5 | Common | Common Stock, par value $0.0001 | 2022-07-01 | S | D | 26,982 | $12.00 | 17,700 | D | — | — | |
| 6 | Derivative | Stock Options (option to buy) | 2022-07-01 | M | D | 22,963 | $0.00 | 15,037 | D | $2.95 · — to 2029-03-26 | 22,963 Common Stock, par value $0.0001 | (F2) Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date. |
| 7 | Derivative | Stock Options (option to buy) | 2022-07-05 | M | D | 787 | $0.00 | 14,250 | D | $2.95 · — to 2029-03-26 | 787 Common Stock, par value $0.0001 | (F2) Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date. |
| 8 | Derivative | Stock Options (option to buy) | 2022-07-01 | M | D | 4,019 | $0.00 | 8,750 | D | $2.60 · — to 2029-01-02 | 4,019 Common Stock, par value $0.0001 | (F2) Twenty-five percent of the shares underlying the option become vested and exercisable on the first anniversary of the Grant Date and the remaining 75% of the shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following the one-year anniversary of the Grant Date, in each case, generally subject to the reporting person's continued service through the applicable vesting date. |